BeOne Medicines Ltd. financial data

Symbol
ONC on Nasdaq, BEIGF on OTC
Location
Basel
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 240% % 23%
Quick Ratio 25% % 13%
Debt-to-equity 77% % 8.4%
Return On Assets 4.1% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,442,259,810 shares 4%
Common Stock, Shares, Outstanding 1,441,075,618 shares 3.9%
Entity Public Float $14,700,000,000 USD 69%
Common Stock, Value, Issued $144,000 USD 4.3%
Weighted Average Number of Shares Outstanding, Basic 1,417,803,727 shares 3.6%
Weighted Average Number of Shares Outstanding, Diluted 1,474,829,908 shares 7.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $5,343,033,000 USD 40%
Research and Development Expense $2,145,868,000 USD 9.9%
Costs and Expenses $4,227,357,000 USD 12%
Operating Income (Loss) $447,136,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $416,854,000 USD
Income Tax Expense (Benefit) $129,921,000 USD 16%
Net Income (Loss) Attributable to Parent $286,933,000 USD
Earnings Per Share, Basic 0.2 USD/shares
Earnings Per Share, Diluted 0.19 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,547,530,000 USD 73%
Accounts Receivable, after Allowance for Credit Loss, Current $865,080,000 USD 28%
Inventory, Net $608,227,000 USD 23%
Assets, Current $6,233,589,000 USD 56%
Property, Plant and Equipment, Net $1,641,678,000 USD 4%
Operating Lease, Right-of-Use Asset $148,184,000 USD 6.4%
Other Assets, Noncurrent $102,418,000 USD -36%
Assets $8,188,573,000 USD 38%
Accounts Payable, Current $479,035,000 USD 18%
Employee-related Liabilities, Current $305,055,000 USD 23%
Accrued Liabilities, Current $1,109,120,000 USD 38%
Liabilities, Current $1,828,830,000 USD -17%
Deferred Income Tax Liabilities, Net $53,209,000 USD 27%
Operating Lease, Liability, Noncurrent $52,940,000 USD 20%
Other Liabilities, Noncurrent $80,245,000 USD 20%
Liabilities $3,827,379,000 USD 48%
Accumulated Other Comprehensive Income (Loss), Net of Tax $78,184,000 USD 48%
Retained Earnings (Accumulated Deficit) $8,319,903,000 USD 3.3%
Stockholders' Equity Attributable to Parent $4,361,194,000 USD 31%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,366,255,000 USD -11%
Liabilities and Equity $8,188,573,000 USD 38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $44,082,000 USD
Net Cash Provided by (Used in) Financing Activities $33,777,000 USD -121%
Net Cash Provided by (Used in) Investing Activities $121,941,000 USD 42%
Common Stock, Shares Authorized 9,500,000,000 shares 0%
Common Stock, Shares, Issued 1,540,975,898 shares 11%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $108,156,000 USD 71%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,609,647,000 USD 75%
Interest Paid, Excluding Capitalized Interest, Operating Activities $6,247,000 USD 175%
Deferred Tax Assets, Valuation Allowance $3,648,017,000 USD 7.2%
Deferred Tax Assets, Gross $3,692,017,000 USD 8.3%
Operating Lease, Liability $73,638,000 USD 19%
Depreciation $131,615,000 USD -21%
Payments to Acquire Property, Plant, and Equipment $56,407,000 USD -64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $357,737,000 USD
Lessee, Operating Lease, Liability, to be Paid $80,569,000 USD 18%
Property, Plant and Equipment, Gross $2,043,214,000 USD 54%
Operating Lease, Liability, Current $20,698,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year Two $21,761,000 USD 64%
Lessee, Operating Lease, Liability, to be Paid, Year One $23,653,000 USD 19%
Operating Lease, Weighted Average Discount Rate, Percent 0.0502 pure -4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,931,000 USD 3.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three $16,453,000 USD 31%
Unrecognized Tax Benefits $27,835,000 USD 61%
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,173,000 USD -4.8%
Additional Paid in Capital $12,759,137,000 USD 5.6%
Amortization of Intangible Assets $10,071,000 USD 109%
Depreciation, Depletion and Amortization $32,804,000 USD 30%
Share-based Payment Arrangement, Expense $510,247,000 USD 15%